SetPoint Medical, a company dedicated to developing therapies for people living with chronic autoimmune diseases, today ...

A new breakthrough study from the Rotman Research Institute at Baycrest, University of Toronto (Motsenyat et al., Brain Stimulation 2025) shows that brief sessions of pulsed photobiomodulation (PBM) ...

Peptides have emerged as critical tools in the investigation of physiological homeostasis, specifically in how biological systems manage energy substrates and recover from physical trauma. By ...

Santa Barbara-based Lucidean, a deep-tech startup working at the cutting edge of optical interconnect technologies, has ...

Bright Minds Biosciences (DRUG) stays a Strong Buy after Phase 2 BMB-101 seizure-reduction data; see 2026 catalysts, ...

Discover LucidMe Pro, a smart AI-powered sleep mask that tracks brain-wave signals in real-time to understand dreams as they ...

"Nia Therapeutics publishes first in vivo validation of SNS" was originally created and published by Medical Device Network, ...

M+ cash runway to 2029, bitopertin FDA NDA/accelerated approval catalyst, and DISC-0974 myelofibrosis data—read now.

A newly released independent research review is contributing fresh scientific perspective to the ongoing discussion around ...

As these systems evolve, I believe therapeutic ultrasound is poised to become medicine's next general-purpose platform.